Baxter Recalls IV Product Due to Particulate Matter

Baxter has voluntarily recalled a specific lot of Cefazolin in Dextrose Injection after particulate matter identified as cardboard was found in the solution. The affected product is used intravenously to treat bacterial infections and help prevent infections during surgery. According to the U.S. Food and Drug Administration, use of the product could potentially lead to serious complications, including pulmonary embolism and inflammation of the veins, although no adverse events have been reported.

Hospitals and other customers are advised to immediately discontinue use of the affected lot and return all impacted products in accordance with their facility’s procedures. Baxter is contacting customers directly with return instructions.

Learn more here.